医渡科技：AI中台持续落地亏损幅度显著收窄

中金公司2025-07-15

公司动态公司近况近期，医渡科技AI医疗业务持续推进，相继推出AI中台2.0 等升级版核心产品，陆续落地头部医院客户。同时，公司发布2025 财年业绩，亏损幅度显著收窄。我们认为，随着行业需求回暖、AI战略聚焦，医渡科技有望推动AI解决方案在医疗行业的扎实落地，并支撑自身业绩的稳健增长。评论深耕AI医疗业务，赋能医疗智能化转型。医渡科技持续深化自研医疗垂域大模型的技术研发与场景赋能，AI中台和...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2551169440?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-15 00:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2551169440","market":"hk","top_or_hot":-1,"title":"医渡科技：AI中台持续落地 亏损幅度显著收窄","media":"中金公司","content":"<div>\n<p>公司动态公司近况近期，医渡科技AI医疗业务持续推进，相继推出AI中台2.0 等升级版核心产品，陆续落地头部医院客户。同时，公司发布2025 财年业绩，亏损幅度显著收窄。我们认为，随着行业需求回暖、AI战略聚焦，医渡科技有望推动AI解决方案在医疗行业的扎实落地，并支撑自身业绩的稳健增长。评论深耕AI医疗业务，赋能医疗智能化转型。医渡科技持续深化自研医疗垂域大模型的技术研发与场景赋能，AI中台和...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715185728a6ab066d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>医渡科技：AI中台持续落地 亏损幅度显著收窄</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n医渡科技：AI中台持续落地 亏损幅度显著收窄\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-15 00:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715185728a6ab066d&s=b><strong>中金公司</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>公司动态公司近况近期，医渡科技AI医疗业务持续推进，相继推出AI中台2.0 等升级版核心产品，陆续落地头部医院客户。同时，公司发布2025 财年业绩，亏损幅度显著收窄。我们认为，随着行业需求回暖、AI战略聚焦，医渡科技有望推动AI解决方案在医疗行业的扎实落地，并支撑自身业绩的稳健增长。评论深耕AI医疗业务，赋能医疗智能化转型。医渡科技持续深化自研医疗垂域大模型的技术研发与场景赋能，AI中台和...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715185728a6ab066d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1617","symbol_name":"AI医疗","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715185728a6ab066d&s=b","article_id":"2551169440","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715185728a6ab066d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2551169440","pubTimestamp":1752508800,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"公司动态公司近况近期，医渡科技AI医疗业务持续推进，相继推出AI中台2.0 等升级版核心产品，陆续落地头部医院客户。同时，公司发布2025 财年业绩，亏损幅度显著收窄。我们认为，随着行业需求回暖、AI战略聚焦，医渡科技有望推动AI解决方案在医疗行业的扎实落地，并支撑自身业绩的稳健增长。AI中台具备数据治理、模型训练、智能体开发等能力，可支持智能病历生成、临床决策辅助、科研服务等多种场景。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1617":"AI医疗","BK1189":"医疗保健技术","02158":"医渡科技","BK1518":"SaaS概念"},"translate_title":"Yidu Technology: AI middle platform continues to land, and losses have narrowed significantly","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02158":1},"content_text":"公司动态公司近况近期，医渡科技AI医疗业务持续推进，相继推出AI中台2.0 等升级版核心产品，陆续落地头部医院客户。同时，公司发布2025 财年业绩，亏损幅度显著收窄。我们认为，随着行业需求回暖、AI战略聚焦，医渡科技有望推动AI解决方案在医疗行业的扎实落地，并支撑自身业绩的稳健增长。评论深耕AI医疗业务，赋能医疗智能化转型。医渡科技持续深化自研医疗垂域大模型的技术研发与场景赋能，AI中台和EYWA数据中台已分别迭代至2.0和5.0 版本，同时公司也基于自研大模型升级推出了针对院管需求的“云析智管”平台和针对科研需求的“云析智研”平台。AI中台具备数据治理、模型训练、智能体开发等能力，可支持智能病历生成、临床决策辅助、科研服务等多种场景。根据公司2025 财年业绩公告，截至2025 年6 月，融合DeepSeek的AI中台已部署超过30 家顶级三甲医院，与中山大学肿瘤防治中心等机构达成了深度合作。业务持续聚焦，亏损幅度收窄。2025 财年，医渡科技录得收入7.1 亿元，同比下降11.4%。其中，大数据平台和解决方案业务收入同比增长10.3%至3.5 亿元，医院和监管机构客户数分别达110 名和44 名；生命科学解决方案收入同比下降23.7%至2.5 亿元，健康管理平台和解决方案收入同比下降28.0%至1.2 亿元，主要受外部市场环境及产品组合变化的影响。在利润端，公司归母净亏损录得1.2 亿元，同比显著收窄（去年同期归母净亏损为1.9 亿元），主要得益于公司持续的降本增效和业务聚焦。展望未来，随着行业环境逐步回暖、核心产品获更多客户认可，我们认为公司或有望实现稳健的收入增长，并在利润端持续减亏。盈利预测与估值我们保持公司2026 财年的收入和归母净利润预测基本不变；引入2027 财年业绩预测：预计收入为8.7 亿元，预计归母净利润为411 万元。维持跑赢行业评级，考虑到公司在AI中台等新业务方向的布局和进展，上调目标价36%至6.8 港元（将估值切换至2026 财年，基于8 倍2026 财年P/S）。公司目前交易于7 倍2026 财年P/S，我们的目标价较当前股价有16%的上行空间。风险行业需求不及预期；竞争加剧；新业务风险。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2551169440","isCrawlerRequest":true}

医渡科技：AI中台持续落地 亏损幅度显著收窄

精彩评论

医渡科技：AI中台持续落地亏损幅度显著收窄